Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308365395> ?p ?o ?g. }
- W4308365395 endingPage "997" @default.
- W4308365395 startingPage "987" @default.
- W4308365395 abstract "Abstract Background Age- and height-adjusted total kidney volume is currently considered the best prognosticator in patients with autosomal dominant polycystic kidney disease. We tested the ratio of urinary epidermal growth factor and monocyte chemotactic peptide 1 for the prediction of the Mayo Clinic Imaging Classes. Methods Urinary epidermal growth factor and monocyte chemotactic peptide 1 levels were measured in two independent cohorts (discovery, n = 74 and validation set, n = 177) and healthy controls ( n = 59) by immunological assay. Magnetic resonance imaging parameters were used for total kidney volume calculation and the Mayo Clinic Imaging Classification defined slow (1A–1B) and fast progressors (1C–1E). Microarray and quantitative gene expression analysis were used to test epidermal growth factor and monocyte chemotactic peptide 1 gene expression. Results Baseline ratio of urinary epidermal growth factor and monocyte chemotactic peptide 1 correlated with total kidney volume adjusted for height ( r = − 0.6, p < 0.001), estimated glomerular filtration rate ( r = 0.69 p < 0.001), discriminated between Mayo Clinic Imaging Classes ( p < 0.001), and predicted the variation of estimated glomerular filtration rate at 10 years ( r = − 0.51, p < 0.001). Conditional Inference Trees identified cut-off levels of the ratio of urinary epidermal growth factor and monocyte chemotactic peptide 1 for slow and fast progressors at > 132 (100% slow) and < 25.76 (89% and 86% fast, according to age), with 94% sensitivity and 66% specificity ( p = 6.51E−16). Further, the ratio of urinary epidermal growth factor and monocyte chemotactic peptide 1 at baseline showed a positive correlation ( p = 0.006, r = 0.36) with renal outcome (delta-estimated glomerular filtration rate per year, over a mean follow-up of 4.2 ± 1.2 years). Changes in the urinary epidermal growth factor and monocyte chemotactic peptide 1 were mirrored by gene expression levels in both human kidney cysts (epidermal growth factor: − 5.6-fold, fdr = 0.001; monocyte chemotactic peptide 1: 3.1-fold, fdr = 0.03) and Pkd1 knock-out mouse kidney ( Egf : − 14.8-fold, fdr = 2.37E-20, Mcp1 : 2.8-fold, fdr = 6.82E−15). Conclusion The ratio of urinary epidermal growth factor and monocyte chemotactic peptide 1 is a non-invasive pathophysiological biomarker that can be used for clinical risk stratification in autosomal dominant polycystic kidney disease." @default.
- W4308365395 created "2022-11-11" @default.
- W4308365395 creator A5001391327 @default.
- W4308365395 creator A5001778467 @default.
- W4308365395 creator A5005934851 @default.
- W4308365395 creator A5011849846 @default.
- W4308365395 creator A5025416134 @default.
- W4308365395 creator A5026528645 @default.
- W4308365395 creator A5027948365 @default.
- W4308365395 creator A5034330930 @default.
- W4308365395 creator A5034689878 @default.
- W4308365395 creator A5037461360 @default.
- W4308365395 creator A5039202658 @default.
- W4308365395 creator A5039618749 @default.
- W4308365395 creator A5045016808 @default.
- W4308365395 creator A5048512133 @default.
- W4308365395 creator A5050449279 @default.
- W4308365395 creator A5050569543 @default.
- W4308365395 creator A5050724379 @default.
- W4308365395 creator A5059086195 @default.
- W4308365395 creator A5063385226 @default.
- W4308365395 creator A5074352097 @default.
- W4308365395 date "2022-11-07" @default.
- W4308365395 modified "2023-09-26" @default.
- W4308365395 title "Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease" @default.
- W4308365395 cites W1612317928 @default.
- W4308365395 cites W1693780222 @default.
- W4308365395 cites W1939694090 @default.
- W4308365395 cites W2038092958 @default.
- W4308365395 cites W2053062434 @default.
- W4308365395 cites W2096538221 @default.
- W4308365395 cites W2101067234 @default.
- W4308365395 cites W2116811919 @default.
- W4308365395 cites W2124577658 @default.
- W4308365395 cites W2124628054 @default.
- W4308365395 cites W2125972182 @default.
- W4308365395 cites W2128761254 @default.
- W4308365395 cites W2140394797 @default.
- W4308365395 cites W2142247849 @default.
- W4308365395 cites W2143108257 @default.
- W4308365395 cites W2162419676 @default.
- W4308365395 cites W2188526593 @default.
- W4308365395 cites W2265762969 @default.
- W4308365395 cites W2285702576 @default.
- W4308365395 cites W2312515686 @default.
- W4308365395 cites W2342344974 @default.
- W4308365395 cites W2510465696 @default.
- W4308365395 cites W2561254660 @default.
- W4308365395 cites W2577378324 @default.
- W4308365395 cites W2762737041 @default.
- W4308365395 cites W2771431842 @default.
- W4308365395 cites W2791240569 @default.
- W4308365395 cites W2890311099 @default.
- W4308365395 cites W2911265062 @default.
- W4308365395 cites W2965382500 @default.
- W4308365395 cites W2970683697 @default.
- W4308365395 cites W3123898773 @default.
- W4308365395 doi "https://doi.org/10.1007/s40620-022-01468-w" @default.
- W4308365395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36342644" @default.
- W4308365395 hasPublicationYear "2022" @default.
- W4308365395 type Work @default.
- W4308365395 citedByCount "0" @default.
- W4308365395 crossrefType "journal-article" @default.
- W4308365395 hasAuthorship W4308365395A5001391327 @default.
- W4308365395 hasAuthorship W4308365395A5001778467 @default.
- W4308365395 hasAuthorship W4308365395A5005934851 @default.
- W4308365395 hasAuthorship W4308365395A5011849846 @default.
- W4308365395 hasAuthorship W4308365395A5025416134 @default.
- W4308365395 hasAuthorship W4308365395A5026528645 @default.
- W4308365395 hasAuthorship W4308365395A5027948365 @default.
- W4308365395 hasAuthorship W4308365395A5034330930 @default.
- W4308365395 hasAuthorship W4308365395A5034689878 @default.
- W4308365395 hasAuthorship W4308365395A5037461360 @default.
- W4308365395 hasAuthorship W4308365395A5039202658 @default.
- W4308365395 hasAuthorship W4308365395A5039618749 @default.
- W4308365395 hasAuthorship W4308365395A5045016808 @default.
- W4308365395 hasAuthorship W4308365395A5048512133 @default.
- W4308365395 hasAuthorship W4308365395A5050449279 @default.
- W4308365395 hasAuthorship W4308365395A5050569543 @default.
- W4308365395 hasAuthorship W4308365395A5050724379 @default.
- W4308365395 hasAuthorship W4308365395A5059086195 @default.
- W4308365395 hasAuthorship W4308365395A5063385226 @default.
- W4308365395 hasAuthorship W4308365395A5074352097 @default.
- W4308365395 hasBestOaLocation W43083653951 @default.
- W4308365395 hasConcept C126322002 @default.
- W4308365395 hasConcept C134018914 @default.
- W4308365395 hasConcept C159641895 @default.
- W4308365395 hasConcept C170493617 @default.
- W4308365395 hasConcept C2776266639 @default.
- W4308365395 hasConcept C2776362946 @default.
- W4308365395 hasConcept C2778653478 @default.
- W4308365395 hasConcept C2780091579 @default.
- W4308365395 hasConcept C2780145431 @default.
- W4308365395 hasConcept C2781184567 @default.
- W4308365395 hasConcept C54166955 @default.
- W4308365395 hasConcept C71924100 @default.
- W4308365395 hasConcept C77411442 @default.
- W4308365395 hasConceptScore W4308365395C126322002 @default.